Total Funding
$1.2M
Employee Range
1-10
MedGene Therapeutics is developing ACT treatments for MSTS and MFTC using patented technology for tumor-reactive T cells. Their focus is on providing innovative solutions for metastatic soft tissue sarcoma and metastatic follicular thyroid cancer.
MedGene Therapeutics data powered by:
Share
MedGene Therapeutics data powered by:
MedGene TherapeuticsOverall Ranking
City Rank
Share
Loading...
In Silver Spring
Top null%out of startups
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
MedGene TherapeuticsIndustry Rankings in
HealthtechCity Rank
Share
2nd
In Silver Spring
Top 67%out of 3 startups
National Rank
Share
6,262nd
In United States
Top 71%out of 8865 startups
Regional Rank
Share
6,676th
In North America
Top 70%out of 9661 startups
MedGene TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Silver Spring
Top 100%out of 1 startups
National Rank
Share
2,740th
In United States
Top 79%out of 3469 startups
Regional Rank
Share
2,888th
In North America
Top 78%out of 3717 startups
rankings by:
MedGene TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
MedGene TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro